Not Tagged
Not Tagged
[]
primary and secondary progressive ms patients with edss scores of 6-6.5 showed walking ability gains after msc-np treatment in phase 2 trial. #aan2023 #news 
We exist to bring you science, research and clinical news about MS. We are a free digital publication dedicated to the patient community.